The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage

被引:13
|
作者
White, C. Roger [1 ]
Datta, Geeta [1 ]
Wilson, Landon [3 ]
Palgunachari, Mayakonda N. [1 ]
Anantharamaiah, G. M. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Targeted Metabol & Prote Lab, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
ApoA-I; ApoA-I mimetic peptide; Hypochlorous acid; Oxidation; Cholesterol efflux; HIGH-DENSITY-LIPOPROTEIN; CORONARY ATHEROSCLEROSIS; HDL; NANOPARTICLES; CHOLESTEROL; DISEASE; MILANO;
D O I
10.1016/j.chemphyslip.2019.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High density lipoprotein (HDL) is prone to modification by the oxidizing and chlorinating agent hypochlorite anion (OCl-). Oxidation of apolipoprotein (apo) A-I, the major protein in HDL, reduces ABCA-1 mediated cholesterol efflux and other protective responses to HDL. The apoA-I mimetic peptide 4F has been shown to undergo oxidation; however, the ability of the peptide to mediate cholesterol efflux remains intact. Here, we show that 4F protects apoA-I from hypochlorite-mediated oxidation. Mass spectral analysis of apoA-I shows that tyrosine residues that are prone to hypochlorite-mediated chlorination are protected in the presence of 4F. Furthermore, 4F enhances the cholesterol efflux ability of apoA-I to a greater extent than either 4F or apoA-I alone, even after hypochlorite oxidation. These observations suggest that apoA-I in lipid complexes may be protected by the presence of 4F, resulting in the preservation of its anti-inflammatory and anti-atherogenic properties. These studies also form the basis for the future studies of nanoparticles possessing both apoA-I and 4F.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [31] Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages
    Smythies, Lesley E.
    White, C. Roger
    Maheshwari, Akhil
    Palgunachari, M. N.
    Anantharamaiah, G. M.
    Chaddha, Manjula
    Kurundkar, Ashish R.
    Datta, Geeta
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 298 (06): : C1538 - C1548
  • [32] ENTHALPY OF ASSOCIATION OF APOLIPOPROTEIN A-I (APOA-I) WITH LECITHIN-CHOLESTEROL MIXTURES
    CHATURVEDI, BK
    MASSEY, JB
    GOTTO, AM
    POWNALL, HJ
    FEDERATION PROCEEDINGS, 1982, 41 (04) : 1021 - 1021
  • [33] IN VITRO PROPERTIES OF AN APOLIPOPROTEIN A-I MIMETIC PEPTIDE
    di Bartolo, B.
    Bursill, C.
    Rye, K-a
    Nicholls, S.
    Heather, A.
    Barter, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [34] Attenuation of Acute Doxorubicin-Induced Cardiotoxicity by the ApoA-I Mimetic Peptide 4-F
    Proctor, J. Bradley
    Zhang, Zhenghao
    White, C. Roger
    FASEB JOURNAL, 2009, 23
  • [35] Apolipoprotein A-I mimetic peptide 4F suppresses PMN-myeloid-derived suppressor cells in mouse pancreatic cancer
    Peng, M.
    Zhang, Q.
    Wu, Y.
    Zhang, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1878 - 1878
  • [36] The ApoA-I peptide mimetic 5A protects against atherosclerosis in apoE deficient mice
    Amar, Marcelo J.
    Basso, Federica
    Demosky, Steve
    Stonick, John
    Remaley, Alan T.
    CIRCULATION, 2006, 114 (18) : 23 - 23
  • [37] Genome-wide Screen for Modulation of Hepatic Apolipoprotein A-I (ApoA-I) Secretion
    Miles, Rebecca R.
    Perry, William
    Haas, Joseph V.
    Mosior, Marian K.
    N'Cho, Mathias
    Wang, Jian W. J.
    Yu, Peng
    Calley, John
    Yue, Yong
    Carter, Quincy
    Han, Bomie
    Foxworthy, Patricia
    Kowala, Mark C.
    Ryan, Timothy P.
    Solenberg, Patricia J.
    Michael, Laura F.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (09) : 6386 - 6396
  • [38] The ApoA-I mimetic peptide, 4F, inhibits LPS-induced inflammatory reactions through Dysregulation of the NFκB activation pathway
    Datta, Geeta
    White, C. R.
    Chaddha, Marijula
    Palgunachari, M. N.
    Anantharamaiah, G. M.
    Smythies, Lesley
    CIRCULATION, 2007, 116 (16) : 209 - 209
  • [39] ApoA-I Mimetic Peptide 4F Suppresses the Elevation of Pro-Inflammatory Lipid Mediators in Mouse Models of Inflammatory Bowel Disease
    Meriwether, David
    Volpe, Carmen
    Grijalva, Victor
    O'Connor, Ellen
    Dorreh, Nasrin
    Fogelman, Alan M.
    Reddy, Srinivasa T.
    CIRCULATION, 2018, 138
  • [40] APOLIPOPROTEIN A-I MIMETIC PEPTIDE 4F BLOCKS SPHINGOMYELINASE-INDUCED LDL AGGREGATION: INTERACTION OF THE AMPHIPATHIC HELICAL PEPTIDE WITH LDL PARTICLES
    Nguyen, S.
    Tero, P.
    Navab, M.
    Fogelman, A.
    Kovanen, P.
    Katariina, O.
    ATHEROSCLEROSIS, 2014, 235 (02) : E22 - E22